Mark Douglas Smith insider trades

Open-market stock purchases and sales by Mark Douglas Smith, Director at Jazz Pharmaceuticals plc, from SEC Form 4 filings since May 30, 2019.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -9%.

Recent trades

DateStockTradeValue
Aug 31, 2026JAZZ Jazz Pharmaceuticals plcSold (not open market)$3.4K
Aug 31, 2026JAZZ Jazz Pharmaceuticals plcSold (not open market)$408K
Aug 5, 2026JAZZ Jazz Pharmaceuticals plcBought (not open market)—
Jun 24, 2026PHR Phreesia, IncBought (not open market)$185K
Jun 15, 2026JAZZ Jazz Pharmaceuticals plcSold$267K
May 21, 2026TDOC Teladoc Health, IncBought (not open market)—

Companies traded

  • JAZZ Jazz Pharmaceuticals plc: 6 sales, last Aug 31, 2026
  • PHR Phreesia, Inc: 8 sales, last Jun 24, 2026
  • TDOC Teladoc Health, Inc: 1 buy, last May 21, 2026

Get free alerts when Mark Douglas Smith files a new trade →